Home
About
Overview
Sharing Data
ORCID
Help
History (1)
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter. Blood Adv. 2018 11 13; 2(21):3070-3080.
View in:
PubMed
subject areas
CCAAT-Enhancer-Binding Proteins
fms-Like Tyrosine Kinase 3
Humans
Leukemia, Myeloid, Acute
Mutation
Neoplasm, Residual
Nuclear Proteins
Remission Induction
Risk Factors
Tumor Suppressor Protein p53
authors with profiles
Gregory Roloff